Home/Filings/4/0001651308-25-000105
4//SEC Filing

Wang Xiaodong 4

Accession 0001651308-25-000105

CIK 0001651308other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 5:39 PM ET

Size

23.7 KB

Accession

0001651308-25-000105

Insider Transaction Report

Form 4
Period: 2025-06-10
Wang Xiaodong
DirectorOther
Transactions
  • Sale

    American Depositary Shares

    2025-06-10$262.20/sh15,878$4,163,26222,981 total
  • Sale

    American Depositary Shares

    2025-06-10$264.08/sh6,787$1,792,314100 total
  • Exercise/Conversion

    Share Option (Right to Buy)

    2025-06-10542,8807 total
    Exercise: $0.50Exp: 2025-07-19Ordinary Shares (542,880 underlying)
  • Award

    Share Option (Right to Buy)

    2025-06-10+185,796185,796 total
    Exercise: $20.26Exp: 2035-06-09Ordinary Shares (185,796 underlying)
  • Exercise/Conversion

    American Depositary Shares

    2025-06-10$6.50/sh+41,760$271,44041,760 total
  • Sale

    American Depositary Shares

    2025-06-10$263.17/sh16,094$4,235,5016,887 total
  • Award

    Ordinary Shares

    2025-06-10+98,6965,180,861 total
  • Sale

    American Depositary Shares

    2025-06-10$261.20/sh2,901$757,75338,859 total
  • Sale

    American Depositary Shares

    2025-06-10$264.85/sh100$26,4850 total
Holdings
  • Ordinary Shares

    (indirect: See Footnote)
    1,025,063
  • Ordinary Shares

    (indirect: See Footnote)
    3,953,100
  • Ordinary Shares

    (indirect: See Footnote)
    50
Footnotes (13)
  • [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.66 to $264.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F11]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
  • [F12]These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
  • [F13]These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service.
  • [F2]These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
  • [F3]These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
  • [F4]These securities are held by the spouse of the Reporting Person.
  • [F5]Each American Depositary Share represents 13 Ordinary Shares.
  • [F6]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.66 to $261.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.66 to $262.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.66 to $263.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Issuer

BeOne Medicines Ltd.

CIK 0001651308

Entity typeother

Related Parties

1
  • filerCIK 0001662982

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:39 PM ET
Size
23.7 KB